Health Tidings ResearchFDA Grants Advanced Manufacturing Technology Designation to Astellas’ Mah... FDA Grants Advanced Manufacturing Technology Designation to Astellas’ Mah... Read Post »
New Drug ApprovalSaphnelo Gains EU Approval for At-Home Subcutaneous Self-Administration in ... Saphnelo Gains EU Approval for At-Home Subcutaneous Self-Administration in ... Read Post »
Health Tidings ResearchBlueRock Therapeutics’ Bemdaneprocel Earns Pioneering Regenerative Medica... BlueRock Therapeutics’ Bemdaneprocel Earns Pioneering Regenerative Medica... Read Post »
Lifestyle Research WellnessCan Smoking Make Asthma Inhalers Less Effective? Can Smoking Make Asthma Inhalers Less Effective? Read Post »
New Drug ApprovalBreakthrough PCSK9 Inhibitor LEROCHOL Approved for Hypercholesterolemia Breakthrough PCSK9 Inhibitor LEROCHOL Approved for Hypercholesterolemia Read Post »
Clinical TrialsPhase 3 ARTISTRY-2 Data Support Bictegravir–Lenacapavir as a Potential Ne... Phase 3 ARTISTRY-2 Data Support Bictegravir–Lenacapavir as a Potential Ne... Read Post »
New Drug ApprovalExdensur (Depemokimab) Secures First Global Approval in the UK, Followed by... Exdensur (Depemokimab) Secures First Global Approval in the UK, Followed by... Read Post »
Health Tidings ResearchNo Patient Identifiers Needed: FDA Removes a Key Barrier to Using Real-Worl... No Patient Identifiers Needed: FDA Removes a Key Barrier to Using Real-Worl... Read Post »
Clinical TrialsFDA Awards National Priority Voucher to Teclistamab Plus Daratumumab as Pha... FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab as Pha... Read Post »
Clinical TrialsMazdutide Shows Strong Weight Loss and Metabolic Benefits in Phase 1b Trial... Mazdutide Shows Strong Weight Loss and Metabolic Benefits in Phase 1b Trial... Read Post »
Food Research WellnessLove Tea but Taking Iron Pills? Read This First Love Tea but Taking Iron Pills? Read This First Read Post »
Clinical TrialsAmneal’s Interim Phase 4 ELEVATE-PD Data Shows Extended “Good On”... Amneal’s Interim Phase 4 ELEVATE-PD Data Shows Extended “Good On”... Read Post »
New Drug ApprovalFDA Approves CARDAMYST™ (Etripamil) as First Self-Administered Nasal Spra... FDA Approves CARDAMYST™ (Etripamil) as First Self-Administered Nasal Spra... Read Post »
Drugs Safety Alert ResearchWHO Review Shows Strong Evidence That Vaccines Are Not Linked to Autism WHO Review Shows Strong Evidence That Vaccines Are Not Linked to Autism Read Post »
New Drug ApprovalNew FDA Approval: Uplizna for gMG in Adults New FDA Approval: Uplizna for gMG in Adults Read Post »
New Drug ApprovalEMA CHMP December 2025 Meeting: 7 New Medicine Approvals and 12 Indication ... EMA CHMP December 2025 Meeting: 7 New Medicine Approvals and 12 Indication ... Read Post »
New Drug ApprovalFDA Approves Nuzolvence (Zoliflodacin): First-in-Class Oral Antibiotic for ... FDA Approves Nuzolvence (Zoliflodacin): First-in-Class Oral Antibiotic for ... Read Post »
Clinical TrialsEli Lilly’s Triple Agonist Retatrutide Hits Phase 3 Goals in Obesity ... Eli Lilly’s Triple Agonist Retatrutide Hits Phase 3 Goals in Obesity ... Read Post »
New Drug ApprovalFDA Approves First Cell-Based Therapy Waskyra for Rare WAS Immunodeficiency FDA Approves First Cell-Based Therapy Waskyra for Rare WAS Immunodeficiency Read Post »
New Drug ApprovalFDA’s First CNPV Approval: Augmentin XR Goes Domestic FDA’s First CNPV Approval: Augmentin XR Goes Domestic Read Post »
Drugs Safety Alert ResearchFDA Alerts on Fake Ozempic in Legitimate US Supply: Novo Nordisk Guidance A... FDA Alerts on Fake Ozempic in Legitimate US Supply: Novo Nordisk Guidance A... Read Post »
New Drug ApprovalFDA Qualifies First AI Tool under Drug Development Tool Program, Paving the... FDA Qualifies First AI Tool under Drug Development Tool Program, Paving the... Read Post »
New Drug ApprovalFDA Approves Omisirge for Severe Aplastic Anemia: A New Option for Patients... FDA Approves Omisirge for Severe Aplastic Anemia: A New Option for Patients... Read Post »
Clinical TrialsVertex CASGEVY Breakthrough: First Data in Children 5-11 at ASH 2025, Globa... Vertex CASGEVY Breakthrough: First Data in Children 5-11 at ASH 2025, Globa... Read Post »
Clinical TrialsBreakthrough Rusfertide Phase 3 VERIFY Results: 52-Week Hematocrit Control ... Breakthrough Rusfertide Phase 3 VERIFY Results: 52-Week Hematocrit Control ... Read Post »
Lifestyle Research WellnessUnderstanding Cannabis: How Medical and Recreational Use Differ in Purpose,... Understanding Cannabis: How Medical and Recreational Use Differ in Purpose,... Read Post »
Clinical TrialsPfizer’s HYMPAVZI Shows 93% Bleed Reduction in Hemophilia A/B with Inhibi... Pfizer’s HYMPAVZI Shows 93% Bleed Reduction in Hemophilia A/B with Inhibi... Read Post »
Clinical TrialsZorevunersen Four-Year Results Confirm Disease-Modifying Potential in Pedia... Zorevunersen Four-Year Results Confirm Disease-Modifying Potential in Pedia... Read Post »
Health Tidings ResearchFDA Moves Toward Real-World Evaluation of Digital Devices With TEMPO Progra... FDA Moves Toward Real-World Evaluation of Digital Devices With TEMPO Progra... Read Post »
Clinical TrialsJnJ’s INLEXZO™ Achieves 74% One-Year Disease-Free Survival in BCG-U... JnJ’s INLEXZO™ Achieves 74% One-Year Disease-Free Survival in BCG-U... Read Post »
Clinical TrialsBayer Launches Phase III SUNFLOWER Trial: Mirena 52mg LNG-IUS for Nonatypic... Bayer Launches Phase III SUNFLOWER Trial: Mirena 52mg LNG-IUS for Nonatypic... Read Post »
Clinical TrialsPositive HOPE-3 Phase 3 Results Support Deramiocel as a Potential New Treat... Positive HOPE-3 Phase 3 Results Support Deramiocel as a Potential New Treat... Read Post »
Health Tidings ResearchAbbott Launches Two New Ensure® Max Protein Shakes: 42g Protein and 2-in-1... Abbott Launches Two New Ensure® Max Protein Shakes: 42g Protein and 2-in-1... Read Post »
New Drug ApprovalFDA Approves Breyanzi as First CAR T-Cell Therapy for Relapsed/Refractory M... FDA Approves Breyanzi as First CAR T-Cell Therapy for Relapsed/Refractory M... Read Post »
Clinical Trials New Drug ApprovalIonis’ Zilganersen Earns FDA Breakthrough Therapy Designation for Ultra R... Ionis’ Zilganersen Earns FDA Breakthrough Therapy Designation for Ultra R... Read Post »
Clinical TrialsLEQEMBI® (Lecanemab-irmb) CTAD 2025 Data Confirms Aβ Protofibril Reductio... LEQEMBI® (Lecanemab-irmb) CTAD 2025 Data Confirms Aβ Protofibril Reductio... Read Post »
New Drug ApprovalSun Pharma Launches Ilumya® in India: A Global Innovative Drug for Moderat... Sun Pharma Launches Ilumya® in India: A Global Innovative Drug for Moderat... Read Post »
New Drug ApprovalBaxdrostat NDA Accepted Under FDA Priority Review for Hard-to-Control High ... Baxdrostat NDA Accepted Under FDA Priority Review for Hard-to-Control High ... Read Post »
Drugs Safety Alert ResearchFDA Seizes 73,000 Illegal 7-OH Opioid Products worth $1M in Missouri: Major... FDA Seizes 73,000 Illegal 7-OH Opioid Products worth $1M in Missouri: Major... Read Post »
Drugs Safety Alert ResearchFDA Final Guidance on QTc Information in Human Prescription Drug and Biolog... FDA Final Guidance on QTc Information in Human Prescription Drug and Biolog... Read Post »
New Drug ApprovalAmneal Secure FDA Nod for Albuterol Inhaler and Cyclosporine Eye Drops in E... Amneal Secure FDA Nod for Albuterol Inhaler and Cyclosporine Eye Drops in E... Read Post »
Clinical TrialsEisai Unveils Breakthrough Etalanetug Data at CTAD 2025: Significant Reduct... Eisai Unveils Breakthrough Etalanetug Data at CTAD 2025: Significant Reduct... Read Post »
New Drug ApprovalUS FDA Accepts Wockhardt’s NDA for Zaynich, Marking a Historic First for ... US FDA Accepts Wockhardt’s NDA for Zaynich, Marking a Historic First for ... Read Post »
Clinical TrialsMerck Presents Promising First-in-Human Data for Alzheimer’s Candidates M... Merck Presents Promising First-in-Human Data for Alzheimer’s Candidates M... Read Post »
Clinical TrialsAbbVie’s Phase 3 ECLIPSE Study Shows Atogepant (AQUIPTA®) Superior t... AbbVie’s Phase 3 ECLIPSE Study Shows Atogepant (AQUIPTA®) Superior t... Read Post »
Health Tidings ResearchEli Lilly Lowers Single-Dose Zepbound Vial Prices Eli Lilly Lowers Single-Dose Zepbound Vial Prices Read Post »
Drugs Safety Alert ResearchAustralia’s TGA Updates Safety Warnings for GLP-1 Receptor Agonists a... Australia’s TGA Updates Safety Warnings for GLP-1 Receptor Agonists a... Read Post »
ResearchWHO Measles Report 2025: Vaccination Triumphs save Millions but Outbreaks W... WHO Measles Report 2025: Vaccination Triumphs save Millions but Outbreaks W... Read Post »
Clinical TrialsOral Mosnodenvir Pill’s Rocky Road: 60% Dengue Success in Phase 2a Tr... Oral Mosnodenvir Pill’s Rocky Road: 60% Dengue Success in Phase 2a Tr... Read Post »
New Drug ApprovalChina’s First Domestic IL-23p19 Antibody PECONDLE Gains NMPA Approval... China’s First Domestic IL-23p19 Antibody PECONDLE Gains NMPA Approval... Read Post »
